Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 1 Jan 2013

Erra Elina O, Askling Helena Hervius, Yoksan Sutee, Rombo Lars, Riutta Jukka, Vene Sirkka, Lindquist Lars, Vapalahti Olli, Kantele Anu

Abstract excerpt

Current Japanese encephalitis vaccines are derived from strains of genotype III, yet heterologous genotypes are emerging in endemic areas. Inactivated vaccines given to European travelers were found to elicit protective levels of neutralizing antibodies against heterologous strains of genotypes I-IV.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Antibodies, Neutralizing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antibodies, Viral

Share to Cross Reactions

Share to Encephalitis, Japanese

Share to Encephalitis Virus, Japanese

Share to Vaccines, Inactivated

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 23074319
DOI: 10.1093/cid/cis883
PMCID: PMC3526254

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes.PMID 23074319Read ↗

Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.Semantic proximity Read ↗

Partial cross-protection between Japanese encephalitis virus genotype I and III in miceSemantic proximity Read ↗

Efficacy of genotype-matched vaccine against re-emerging genotype V Japanese encephalitis virus.Semantic proximity Read ↗

Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.Semantic proximity Read ↗

Cross-protection induced by Japanese encephalitis vaccines against different genotypes of Dengue viruses in mice.Semantic proximity Read ↗

Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine.Semantic proximity Read ↗

Comparison of Neutralizing Antibody Titers against Japanese Encephalitis Virus Genotype V Strain with Those against Genotype I and III Strains in the Sera of Japanese Encephalitis Patients in Japan in 2016.Semantic proximity Read ↗

Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: A two-year follow-up studySemantic proximity Read ↗

Study on the Protective Efficacy of the Japanese Encephalitis Live Attenuated Vaccine SA14-14-2 Against Newly Isolated Genotype I Japanese Encephalitis Viruses.Semantic proximity Read ↗

Shift in dominant genotypes of Japanese encephalitis virus and its impact on current vaccination strategiesSemantic proximity Read ↗

Virulence and Cross-Protection Conferred by an Attenuated Genotype I-Based Chimeric Japanese Encephalitis Virus Strain Harboring the E Protein of Genotype V in Mice.Semantic proximity Read ↗

Genotype-specific neutralization determinants in envelope protein: implications for the improvement of Japanese encephalitis vaccine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.